Lv21
160 积分 2025-07-19 加入
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
1小时前
已完结
Post Traumatic Complications After Navicular Fractures
3个月前
已关闭
Acute Fractures of the Tarsal Navicular
3个月前
已完结
Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas
6个月前
已关闭
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)
6个月前
已完结
Real-world outcomes of lenvatinib therapy for advanced neuroendocrine neoplasms
6个月前
已完结
皖公网安备34019202002308
